283 related articles for article (PubMed ID: 26802121)
21. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
[TBL] [Abstract][Full Text] [Related]
22. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
[TBL] [Abstract][Full Text] [Related]
23. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
Fusco F; Pescatore A; Conte MI; Mirabelli P; Paciolla M; Esposito E; Lioi MB; Ursini MV
Int Rev Immunol; 2015; 34(6):445-59. PubMed ID: 26269396
[TBL] [Abstract][Full Text] [Related]
24. Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.
Ohnishi H; Kishimoto Y; Taguchi T; Kawamoto N; Nakama M; Kawai T; Nakayama M; Ohara O; Orii K; Fukao T
J Clin Immunol; 2017 Aug; 37(6):529-538. PubMed ID: 28702714
[TBL] [Abstract][Full Text] [Related]
25. Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression.
Xiong Y; Qiu F; Piao W; Song C; Wahl LM; Medvedev AE
J Biol Chem; 2011 Mar; 286(10):7905-7916. PubMed ID: 21220427
[TBL] [Abstract][Full Text] [Related]
26. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
27. Immune deficiency caused by impaired expression of nuclear factor-kappaB essential modifier (NEMO) because of a mutation in the 5' untranslated region of the NEMO gene.
Mooster JL; Cancrini C; Simonetti A; Rossi P; Di Matteo G; Romiti ML; Di Cesare S; Notarangelo L; Geha RS; McDonald DR
J Allergy Clin Immunol; 2010 Jul; 126(1):127-32.e7. PubMed ID: 20542322
[TBL] [Abstract][Full Text] [Related]
28. A novel missense mutation in the nuclear factor-κB essential modulator (NEMO) gene resulting in impaired activation of the NF-κB pathway and a unique clinical phenotype presenting as MRSA subdural empyema.
Devora GA; Sun L; Chen Z; van Oers NS; Hanson EP; Orange JS; de la Morena MT
J Clin Immunol; 2010 Nov; 30(6):881-5. PubMed ID: 20652730
[TBL] [Abstract][Full Text] [Related]
29. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.
Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F
Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029
[TBL] [Abstract][Full Text] [Related]
30. Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation.
Nagabhushana A; Bansal M; Swarup G
PLoS One; 2011 Mar; 6(3):e17477. PubMed ID: 21408173
[TBL] [Abstract][Full Text] [Related]
31. Liquid phase separation of NEMO induced by polyubiquitin chains activates NF-κB.
Du M; Ea CK; Fang Y; Chen ZJ
Mol Cell; 2022 Jul; 82(13):2415-2426.e5. PubMed ID: 35477005
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cells from humans with hypomorphic mutations in IKBKG/NEMO have impaired mitogen-activated protein kinase activity.
Ma CA; Wang HY; Temmerman S; Zhao Y; Wu L; Hornung RL; Wara D; Jain A
Hum Mutat; 2011 Mar; 32(3):318-24. PubMed ID: 21309033
[TBL] [Abstract][Full Text] [Related]
33. DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.
Grubisha O; Kaminska M; Duquerroy S; Fontan E; Cordier F; Haouz A; Raynal B; Chiaravalli J; Delepierre M; Israël A; Véron M; Agou F
J Mol Biol; 2010 Jan; 395(1):89-104. PubMed ID: 19854204
[TBL] [Abstract][Full Text] [Related]
34. Emergence of the A20/ABIN-mediated inhibition of NF-κB signaling via modifying the ubiquitinated proteins in a basal chordate.
Yuan S; Dong X; Tao X; Xu L; Ruan J; Peng J; Xu A
Proc Natl Acad Sci U S A; 2014 May; 111(18):6720-5. PubMed ID: 24753567
[TBL] [Abstract][Full Text] [Related]
35. Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP.
Zhu G; Wu CJ; Zhao Y; Ashwell JD
Curr Biol; 2007 Aug; 17(16):1438-43. PubMed ID: 17702576
[TBL] [Abstract][Full Text] [Related]
36. Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotype.
Lee Y; Wessel AW; Xu J; Reinke JG; Lee E; Kim SM; Hsu AP; Zilberman-Rudenko J; Cao S; Enos C; Brooks SR; Deng Z; Lin B; de Jesus AA; Hupalo DN; Piotto DG; Terreri MT; Dimitriades VR; Dalgard CL; Holland SM; Goldbach-Mansky R; Siegel RM; Hanson EP
J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35289316
[TBL] [Abstract][Full Text] [Related]
37. The zinc finger domain of IKKγ (NEMO) protein in health and disease.
Shifera AS
J Cell Mol Med; 2010 Oct; 14(10):2404-14. PubMed ID: 20345847
[TBL] [Abstract][Full Text] [Related]
38. Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation.
Bannon A; Zhang SD; Schock BC; Ennis M
Med Princ Pract; 2015; 24(4):301-10. PubMed ID: 25925366
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of serine 68 in the IkappaB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappaB activity.
Palkowitsch L; Leidner J; Ghosh S; Marienfeld RB
J Biol Chem; 2008 Jan; 283(1):76-86. PubMed ID: 17977820
[TBL] [Abstract][Full Text] [Related]
40. USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms.
Yang Z; Xian H; Hu J; Tian S; Qin Y; Wang RF; Cui J
Sci Rep; 2015 Aug; 5():12738. PubMed ID: 26240016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
